Buy & Sell HCA Health Inc (HCA) – HCA Health Inc Price Today
Aura AI Summary
Key Stats
- $86.89BMarket Cap
- HealthSector
- -28.76%3M Drawdown
- $135.80BEnterprise Value
- 0.8%Dividend Yield
- 72 daysTypical Hold Time
HCA Health Inc (HCA) is currently valued at a market capitalization of $86.89B, with an enterprise value of $135.80B. Over the past 52 weeks, HCA Health Inc has traded between a low of $334.32 and a high of $545.13, highlighting its annual price range. Over the past three months, HCA Health Inc has recorded a drawdown of -28.76%, reflecting recent price volatility. HCA Health Inc offers a dividend yield of 0.8%, with the most recent dividend of $0.78 paid on 16 Jun 26. On average, investors hold HCA Health Inc for approximately 72 days, indicating typical investor behavior on the platform.
About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Most Recent News
Exosens wins contract to supply 17,000 night vision tubes to Czech Armed Forces through 2032
Exosens has secured a long-term contract with BROLIS to supply approximately 17,000 high-performance image intensifier tubes for the Czech Armed Forces through 2032. This is the largest procurement of such tubes by the Czech Republic, highlighting th...

Global LED packaging market to reach $27.21B by 2035, driven by energy-efficient lighting and smart tech growth.
The global LED packaging market, valued at $17.56 billion in 2025, is projected to grow to $27.21 billion by 2035 with a CAGR of 4.5%. Growth is fueled by rising demand for energy-efficient lighting, smart infrastructure, and advanced automotive ligh...

Oxidative Stress Assay Market to hit $3.25B by 2035, driven by chronic disease and pharma R&D growth
The global Oxidative Stress Assay Market, valued at $1.31 billion in 2025, is projected to reach $3.25 billion by 2035, growing at a CAGR of 9.53%. Growth is fueled by rising chronic diseases, pharmaceutical innovation, and advances in biomarker diag...
